We examined leukemic lymphocyte precursors from ALL patients as well as imm
ortalized ALL cell lines for cytoplasmic histamine expression. The histamin
e levels ranged from 10.8 pg/10(6) cells to 82.2 pg/10(6) cells in ALL cell
Lines (N=4) and from 12.5 pg/10(6) cells to 1235.4 pg/10(6) cells for prim
ary leukemic cells from ALL patients (N=13). The presence of histamine in t
he cytoplasm of these ALL cells was also confirmed by immunostaining using
a polyclonal rabbit anti-histamine antibody. Notably, the histamine recepto
r blocker diphenhydramine inhibited the clonogenic growth of ALL cells by >
90% prompting the hypothesis that histamine may be an autocrine regulator o
f ALL cell proliferation. Our study suggests that histamine receptor blocke
rs may therefore be useful for the treatment of therapy-refractory ALL.